Specifically, genetic deletion of Shh in pancreatic cancer cells decreases survival and enhances tumor progression (Lee et al., 2014; Rhim et al., 2014), and deletion of Smo in bladder stromal cells promotes carcinogenesis (Shin et al., 2014). This evidence concerns the gene SMO and familial pancreatic carcinoma.